Keratoconus in Thyroid Gland Dysfunction Clinical Trial
Official title:
Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
NCT number | NCT04346992 |
Other study ID # | R109 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 12, 2020 |
Est. completion date | March 15, 2022 |
Verified date | September 2022 |
Source | Fayoum University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease
Status | Completed |
Enrollment | 400 |
Est. completion date | March 15, 2022 |
Est. primary completion date | March 15, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - All patients diagnosed as thyroid gland dysfunction Exclusion Criteria: - Uncooperative patients |
Country | Name | City | State |
---|---|---|---|
Egypt | Fayoum University | Fayoum |
Lead Sponsor | Collaborator |
---|---|
Fayoum University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | prevalence of keratoconus in thyroid gland dysfunction | Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:
VA Refraction K reading Slit lamp examination Pentacam |
we will recruit patients who meer the inclusion criteria during the study period April-August 2020 |